• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 25, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Discovery may point to Parkinson’s disease therapies

Bioengineer by Bioengineer
May 27, 2021
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

University of Guelph researchers have discovered a key way Parkinson’s disease spreads in the brain

IMAGE

Credit: University of Guelph

A new discovery by University of Guelph researchers may ultimately help in devising new therapies and improving quality of life for people with Parkinson’s disease.

By showing how entangled proteins in brain cells enable the neurodegenerative disease to spread, the researchers hope their findings will lead to drugs that halt its progression, said PhD candidate Morgan Stykel, first author of a paper published this month in Cell Reports.

Parkinson’s disease is the world’s fastest-growing neurodegenerative disease and Canada has some of the world’s highest rates, according to Parkinson Canada. Its exact cause is unknown.

Current therapies only treat symptoms rather than halting the disease, said Dr. Scott Ryan, a professor in the Department of Molecular and Cellular Biology who led the study.

Parkinson’s disease can be triggered by the misfolding of a protein called alpha-synuclein that accumulates in a part of the brain called the substantia nigra. The disease causes loss of nerve cells in the brain that produce dopamine, a chemical messenger that helps control motor function.

Misfolded alpha-synuclein aggregates and eventually spreads to other parts of the brain, impairing areas responsible for other functions such as mood and cognition.

The U of G team used stem cells to model neurons with and without Parkinson’s disease and look at the effects of synuclein mutations.

They discovered that in Parkinson’s neurons, misfolded synuclein binds to another protein called LC3B. Normally, LC3B targets misfolded proteins to be degraded. In Parkinson’s disease, the study showed, LC3 gets trapped in the protein aggregates and is inactivated.

Without degradation, the cells eject the aggregates, which then spread to nearby neurons, propagating the disease throughout the brain.

“Normally misfolded proteins are degraded. We found a pathway by which synuclein is being secreted and released from neurons instead of being degraded,” said Ryan. “We hope to turn the degradation pathway back on and stop the spread of disease.”

The team showed that activating LC3B restores degradation, enabling cells to clear the misfolded proteins and prevent disease spread.

“Regular protein turnover is part of a healthy cell,” said Stykel. “With Parkinson’s disease, that system is not working properly.”

Ryan said their finding could help in devising therapies.

“We may not be able to do anything about brain regions that are already diseased, but maybe we can stop it from progressing. We might be able to turn the degradation pathway back on and stop the spread of the disease.”

He cautioned that other biochemical pathways are also likely involved in the spread of the disease through the brain. Still, the finding provides a target for potential drug development.

“Most current therapies centre around increasing the release of dopamine, but that works for a brief period and has a lot of side effects,” said Ryan.

This research may help improve quality of life for Parkinson’s patients. Many patients are diagnosed in their 40s or 50s, meaning that they live with the progressive disease for decades.

“Reduced quality of life can be a huge burden on patients, their families and the health-care system,” he said.

###

Media Contact
Dr. Scott Ryan
[email protected]

Original Source

https://news.uoguelph.ca/2021/05/u-of-g-discovery-may-point-to-parkinsons-disease-therapies/

Related Journal Article

http://dx.doi.org/10.1016/j.celrep.2021.109099

Tags: Medicine/HealthneurobiologyNeurochemistryParkinson
Share12Tweet8Share2ShareShareShare2

Related Posts

Increase in Hospice and Palliative Care Consultations Observed in Emergency Departments

Increase in Hospice and Palliative Care Consultations Observed in Emergency Departments

September 25, 2025

Duke Researchers Find Strong Connection Between Childhood Stress and Adult Chronic Disease

September 25, 2025

Flavored Marijuana Vapes Emerge as Leading Trend in Teen Substance Use, Raising Concerns Over Addiction

September 25, 2025

Modeling Bridging Vein Rupture and Hematoma Growth

September 25, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    76 shares
    Share 30 Tweet 19
  • Physicists Develop Visible Time Crystal for the First Time

    71 shares
    Share 28 Tweet 18
  • Scientists Discover and Synthesize Active Compound in Magic Mushrooms Again

    53 shares
    Share 21 Tweet 13
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

New Publication Offers Blueprint for Creating Human-Centric AI Systems

Increase in Hospice and Palliative Care Consultations Observed in Emergency Departments

Innovative Pan-Cancer Immunotherapy Targets Tumors While Sparing Healthy Tissue, UC Irvine Study Finds

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.